Lansdowne Partners Limited Partnership’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
$22.1M Buy
2,321,865
+300,954
+15% +$2.86M 0.19% 33
2013
Q4
$13.1M Hold
2,020,911
0.11% 30
2013
Q3
$15.3M Buy
2,020,911
+286,046
+16% +$2.17M 0.17% 24
2013
Q2
$20.1M Buy
+1,734,865
New +$20.1M 0.25% 26